Moreover, the engineered E. coli with l-asparaginase biosynthesis gene has the potential pharmaceutical and industrial application, since it can produce the glutaminase free anti-tumour enzyme at high rates and can avoid the complex down streaming process associated with conventional bioprocess. Here, GLS is linked to neoplasm.